The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PMVP FINANCIAL STATEMENTS

Pmv Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

PMVPPmv Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-75 M-50 M-25 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-99 K $ · -Infinity%Operating Income-79.7 M $ · -Infinity%Pre-tax Income-75.2 M $ · -Infinity%Net Income to Owners-75.2 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit-99 K $—
Operating Income-79.7 M $—
EBITDA-75.9 M $—
Net Income to Owners-75.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets82.1 M
  • Equity71.5 M $87%
  • Current Liabilities10.6 M $13%

Key Figures

YoY change
Total Assets82.1 M $-46.3%
Total Liabilities10.6 M $-13.7%
Total Equity71.5 M $-49.1%
Cash & ST Investments79.4 M $-44.2%
Total Debt217 K $-78.7%
Net Debt-12.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-75 M-50 M-25 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-60 M-40 M-20 M0-71.3 M $Operating39.1 M $Investing535 K $Financing-31.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-71.3 M $—
Capital Expenditures16 K $-77.8%
Free Cash Flow-71.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PMVP

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.